Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073256 | SCV001238792 | likely pathogenic | Retinal dystrophy | 2018-09-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001090299 | SCV001245750 | pathogenic | not provided | 2018-11-01 | criteria provided, single submitter | clinical testing | |
DBGen Ocular Genomics | RCV001593252 | SCV001815967 | pathogenic | Retinitis pigmentosa 88 | 2021-06-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001090299 | SCV001988418 | uncertain significance | not provided | 2019-05-07 | criteria provided, single submitter | clinical testing | Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 2032 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 30025130, 33576794) |
Prevention |
RCV003405291 | SCV004108858 | pathogenic | RP1L1-related disorder | 2023-07-06 | criteria provided, single submitter | clinical testing | The RP1L1 c.1107G>A variant is predicted to result in premature protein termination (p.Trp369*). This variant has been reported in the homozygous state in individuals with Retinitis pigmentosa (Zobor et al. 2018. PubMed ID: 30025130; Weisschuh et al. 2020. PubMed ID: 32531858. Table S1). This variant has also been reported in the heterozygous state in an individual with retinal disorders (Colombo et al. 2021. PubMed ID: 33576794. Table S3). This variant is reported in 0.0071% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-10470501-C-T). Nonsense variants in RP1L1 are expected to be pathogenic. This variant is interpreted as pathogenic. |